Lpath Inc receives Investment Bank Analyst Rating Update
Investing.com – U.S. stocks were lower after the close on Friday, as losses in the Technology, Basic Materials and Industrials sectors led shares lower. At the close in NYSE, the...
Gainers: Novelion Therapeutics (NASDAQ:NVLN) +46%. ReTo Eco-Solutions (NASDAQ:RETO) +32%. Pro-Dex (NASDAQ:PDEX) +28%. Revlon (NYSE:REV) +25%. Finisar (NASDAQ:FNSR) +18%....
Walgreens Boots Alliance (NASDAQ:WBA), Inc. WBA and Village MD recently announced plans to open eight new Village Medical at Walgreens primary care and pharmacy practices in the...
STERIS plc STE is well poised for growth in the coming months, backed by strong segmental performance. Further, the bullish fiscal 2022 outlook is encouraging. However, stiff...
Alcon (NYSE:ALC) Inc. ALC recently announced an addition to its advanced portfolio of dry eye products with the European launch of Systane Complete Preservative-Free Lubricant Eye...
Apollo Endosurgery, Inc. is a medical technology company, which is focused on the development of medical devices to advance gastrointestinal therapeutic endoscopy. The Company develops and distributes devices that are used by surgeons and gastroenterologists for various procedures related to gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. The Company's products include the OverStitch Endoscopic Suturing System, which enables advanced endoscopic procedures from within the Gastrointestinal tract, or endolumenally, by allowing physicians to suture, especially full-thickness, and secure the approximation of tissue. The X-Tack Endoscopic HeliX Tacking System is a suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract. The Orbera Intragastric Balloon System is a non-surgical alternative for interventional weight loss.